Cassava Sciences(SAVA) - 2023 Q4 - Annual Results

EXHIBIT 99.1 Cassava Sciences Reports Full-year 2023 Financial Results and Corporate Updates AUSTIN, Texas, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company focused on Alzheimer's disease, today reported financial and operating results for the full year ended December 31, 2023 and presented corporate updates. "I see Alzheimer's disease as one of the last great frontiers in medicine," said Remi Barbier, President & CEO. "It's clear to me these patients need new ...